title: Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity.
abstract: Infection of HeLa cells with poliovirus leads to rapid shut-off of host cell transcription by RNA polymerase II. Previous results have suggested that both the basal transcription factor TBP (TATA-binding protein) and transcription activator proteins such as CREB (cyclic AMP-responsive element-binding protein) and Oct-1 (the octamer-binding factor) are cleaved by the viral-encoded protease, 3C(Pro). Here we demonstrate that the transcriptional activator (and tumor suppressor) p53 is degraded by the viral protease 3C both in vivo and in vitro. Unlike other transcription factors that are directly cleaved by 3C(pro), degradation of p53 requires a HeLa cell activity in addition to 3C(Pro). The degradation of p53 by 3C(Pro) does not appear to involve the ubiquitin pathway of protein degradation. Vaccinia virus infection of HeLa cells leads to inactivation of the cellular activity required for 3C(Pro)-mediated degradation of p53. The vaccinia-encoded protein (CrmA) is known to inhibit caspase I (ICE protease) that converts inactive IL-1beta to an active secreted form. Incubation of HeLa cells with caspase I inhibitor Z-VAD-fmk does not interfere with 3C(Pro)-mediated degradation of p53. The cellular activity present in extracts of HeLa cells can be fractionated through phosphocellulose. A partially purified fraction that elutes at 0.6 M KCl from phosphocellulose contains the activity that degrades p53 in a 3C(Pro)-dependent manner. These results suggest that both poliovirus-encoded protease 3C(Pro) and a cellular activity are required for the degradation of p53 observed in cells infected with poliovirus.
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-1747, USA.
authors.forename: M K
authors.initials: MK
authors.lastname: Weidman
authors.forename: P
authors.initials: P
authors.lastname: Yalamanchili
authors.forename: B
authors.initials: B
authors.lastname: Ng
authors.forename: W
authors.initials: W
authors.lastname: Tsai
authors.forename: A
authors.initials: A
authors.lastname: Dasgupta
mesh_terms: D000086042:3C Viral Proteases; D002458:Cell Fractionation; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D017955:Poliovirus / Q000201:enzymology*; D015534:Trans-Activators / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D014616:Vaccinia virus / Q000378:metabolism / Q000502:physiology; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: D015534:Trans-Activators; D016159:Tumor Suppressor Protein p53; D014764:Viral Proteins; D003546:Cysteine Endopeptidases; D000086042:3C Viral Proteases